Perfected by Nature,
Backed by Science.
CLINICAL EVIDENCE (BD-CT-2025-01)
A 90-day Prospective Open-label Single-arm Clinical Trial (BD-CT-2025-01) evaluated the efficacy and safety profile of Betterdays Triple Bioactive Peptides formulation in 80 adult participants. The summary below presents key laboratory observations after 90 days:
average reduction over 90 days
average reduction over 90 days
BETTERDAYS OUTCOMES REGISTRY
The Betterdays Outcomes Registry represents TEONE's commitment to continuously building scientific evidence through real-world product usage evaluation, even after clinical trials have concluded. This observational registry complements clinical research by documenting participant-reported outcomes and available laboratory results during the 90-Day Program.
Participant-Reported Outcomes
Summary of changes reported by participants during the program.
78%
Participants reported improved sleep.
80%
Participants reported more stable daily blood sugar.
85%
Participants reported increased daily energy.
89%
Participants reported reduced sugar cravings.
Laboratory Measurements
Comparison of laboratory results before and after the program among participants with available baseline and follow-up data.
8.4% → 6.9%
Based on 42 participants with baseline and follow-up HbA1c data.
162 → 118 mg/dL
Based on 98 participants with baseline and follow-up fasting glucose data.
78.5 → 73.2 kg
Based on 156 participants with baseline and follow-up body weight data.
142/90 → 124/80 mmHg
Based on 120 participants with baseline and follow-up blood pressure data.
The Betterdays Outcomes Registry documents real-world program outcomes (real-world evidence). These findings represent observational data capturing participant-reported outcomes and available laboratory metrics, complementing ingredient research.
The registry dashboard allows you to explore results by participant characteristics and baseline conditions.
"If I were to sum it up, the BETTERDAYS formula is truly effective for organ health. Especially for those with Diabetes—well, we all know that Diabetes is a systemic issue, and the most important thing to care for is the system itself and the organs that have already been impacted. I hope many more people can learn about this long-term solution."
